Last updated on January 2014

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza


Brief description of study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza

Detailed Study Description

A 5 day trial evaluating Favipiravir (oral medication) vs. placebo in patients with the Flu.

Clinical Study Identifier: TX137747

Find a site near you

Start Over

California Center for Clinical Research

207 S. Santa Anita St.<br /> Suite G16 San Gabriel, CA USA
  Connect »